RMT-101 IGNOU Solved Assignment 2026-27

RMT-101 Solved Assignment 2026-27 (TMA) Verified Solutions for IGNOU Academic Coursework

The RMT-101 Solved Assignment for the 2026-27 session is meticulously crafted to address the mandatory TMA requirements (30% weightage) under the IGNOU Degree Programme. Below are the core syllabus units covered, along with structured answers and key clarifications:

Core Syllabus Units Covered

• Unit 1: Introduction to Radiotherapy and Its Role in Oncology
  • Key concepts: Definition, historical evolution, and principles of radiotherapy in cancer treatment.
  • FAQ: What distinguishes radiotherapy from other cancer therapies? Radiotherapy uses high-energy radiation to destroy cancer cells while sparing healthy tissue, unlike chemotherapy (systemic) or surgery (local excision).
• Unit 2: Physics of Radiation Therapy
  • Topics: Interaction of radiation with matter, linear accelerator technology, and dose calculation.
  • FAQ: How is radiation dose measured in clinical practice? Dose is measured in Gray (Gy), where 1 Gy = 1 Joule/kg of tissue. Planning systems ensure precise delivery to target volumes.
• Unit 3: Radiotherapy Techniques and Modalities
  • Focus: 3D Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Brachytherapy.
  • FAQ: Why is IMRT preferred for complex tumors? IMRT tailors radiation dose distribution to conform to tumor shapes, minimizing exposure to critical organs.
• Unit 4: Clinical Applications and Case Studies
  • Case studies: Breast cancer, lung cancer, and pediatric oncology radiotherapy protocols.
  • FAQ: What are the common side effects of radiotherapy? Acute effects include skin reactions and fatigue; long-term risks include secondary malignancies or fibrosis.
• Unit 5: Quality Assurance and Safety in Radiotherapy
  • Topics: Dosimetry verification, imaging techniques (CT/MRI), and regulatory compliance (ISO standards).

Assignment Structure and Submission Guidelines

The solved assignment follows the IGNOU TMA format with:

• Word Limits: Strict adherence to 500 words (for essay-type questions), 250 words (short answers), and 100 words (multiple-choice explanations).
• Plagiarism-Free: All responses are original, referencing official IGNOU textbooks and guidelines.
• Deadline Compliance: Solutions align with the 2026-27 submission deadlines (e.g., 31st October/31st April).

Note: This digital PDF includes step-by-step reasoning for numerical problems (e.g., dose calculations) and case-based discussions with clinical relevance.